The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.
Navigating New Options to Improve Outcomes in Multiple Myeloma
| Overview / Abstract: |
As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for reimbursement and demonstrate evidence-based, guideline-adherent quality care. |
|
Expiration |
Feb 06, 2019 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
AACME - 1.25 AMA PRA Category 1 Credit TM, ACPE - 1.25 hours (0.125 CEUs), ANCC -1.4 contact hours, APRN - 0.5 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses. |
|
Accreditation |
AACME, ACPE, ANCC, APRN |
|
Presenters / Authors / Faculty |
Roger K. Strair, MD, PhD |
|
Activity Specialities / Related Topics |
Hematology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by independent educational grants from AstraZeneca, Genentech, Lilly, and Novartis Pharmaceuticals Corporation. For further information concerning Lilly grant funding visit www.lillygrantoffice.com. |
|
Keywords / Search Terms |
Rockpointe Free CME, CME, RN, APN, NP, Advance Practice Nurse, Registered Nurse, Nurse Practitioner, Physician, Pharmacist, Oncology, Multiple Myeloma, Hematology Free CE CME |
|